LDRT combined with anti-PD-1 promotes tumor regression in head and neck squamous cell carcinoma through tumor metaprogram evolution and immune cell reprogramming

Abstract Background Anti–PD-1 (αPD-1) therapy shows limited efficacy in head and neck squamous cell carcinoma (HNSCC), partly due to an immunosuppressive tumor microenvironment (TME) and insufficient infiltration of effector T cells. Low-dose radiotherapy (LDRT) has been suggested to modify the TME,...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Guanjun Li, Xiangdi Yang, Linxuan Huang, Yannan Zheng, Liangfu Xu, Zhaoyuan Zhang, Junyan Li, Tingting Li, Yutong Zhang, Yongqin Yang, Yifei Li, Zhigang Liu
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	BMC 2026-02-01
سلاسل:	Journal of Experimental & Clinical Cancer Research
الموضوعات:	Neoadjuvant therapy Low-Dose radiotherapy Immunotherapy Head and neck squamous cell carcinoma
الوصول للمادة أونلاين:	https://doi.org/10.1186/s13046-026-03660-3
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!